BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33668657)

  • 1. Natural Antioxidants in Anemia Treatment.
    Cotoraci C; Ciceu A; Sasu A; Hermenean A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin and Anemia: A Tight Relationship.
    Pagani A; Nai A; Silvestri L; Camaschella C
    Front Physiol; 2019; 10():1294. PubMed ID: 31649559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.
    Liu J; Sun B; Yin H; Liu S
    Medicine (Baltimore); 2016 Apr; 95(14):e3150. PubMed ID: 27057839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron dysregulation and anemias].
    Ikuta K
    Rinsho Ketsueki; 2015 Oct; 56(10):1903-13. PubMed ID: 26458428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.
    Lepanto MS; Rosa L; Cutone A; Conte MP; Paesano R; Valenti P
    Front Immunol; 2018; 9():2123. PubMed ID: 30298070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic value of combined therapy with deferiprone and silymarin as iron chelators in Egyptian children with beta thalassemia major.
    Hagag AA; Elfaragy MS; Elrifaey SM; Abd El-Lateef AE
    Infect Disord Drug Targets; 2015; 15(3):189-95. PubMed ID: 26239735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
    Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
    Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes.
    Ohnishi ST; Ohnishi T
    J Nutr; 2001 Mar; 131(3s):1085S-92S. PubMed ID: 11238822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin.
    Agarwal AK; Yee J
    Adv Chronic Kidney Dis; 2019 Jul; 26(4):298-305. PubMed ID: 31477260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases.
    Poggiali E; Migone De Amicis M; Motta I
    Eur J Intern Med; 2014 Jan; 25(1):12-7. PubMed ID: 23988263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
    Wang C; Fang Z; Zhu Z; Liu J; Chen H
    Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity.
    Boshuizen M; van der Ploeg K; von Bonsdorff L; Biemond BJ; Zeerleder SS; van Bruggen R; Juffermans NP
    Blood Rev; 2017 Nov; 31(6):400-405. PubMed ID: 28755795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin and its role in inflammatory bowel disease.
    Dudkowiak R; Neubauer K; Poniewierka E
    Adv Clin Exp Med; 2013; 22(4):585-91. PubMed ID: 23986220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron dysregulation in beta-thalassemia.
    Leecharoenkiat K; Lithanatudom P; Sornjai W; Smith DR
    Asian Pac J Trop Med; 2016 Nov; 9(11):1035-1043. PubMed ID: 27890361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Hepcidin Concentration in Individuals with Sickle Cell Anemia: Basis for the Dietary Recommendation of Iron.
    Omena J; Cople-Rodrigues CDS; Cardoso JDDA; Soares AR; Fleury MK; Brito FDSB; Koury JC; Citelli M
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29673144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A; Alaraby I; Abdel Kader MS; Ahmed DH; Abdelrahman HE
    Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
    Fibach E; Rachmilewitz EA
    Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.